نتایج جستجو برای: hematological malignancy

تعداد نتایج: 81838  

Journal: :Cureus 2023

Malignant pericardial effusion (MPE) is a slowly progressive and potentially clinically silent condition. Pericardial can arise in oncology patients due to several factors, including disease spreading directly or metastatically, anticancer therapy side effects, both. Solid hematological malignancy metastasis more frequently involves the pericardium than primary tumors, with lung cancer being mo...

Journal: :Turkish journal of internal medicine 2021

Rhabdomyosarcoma caused bone marrow metastasis cases are among the rarest reported in literature. Similar to literature, clinical presentation of our patient mimicked acute leukemia, and leukoerythroblastosis peripheral smear test cytopenia hemogram raised suspicion hematological malignancy initially.1,2 The diagnosis made by immunohistochemical staining biopsy. primary tumor field could not be...

2016
Giuseppe La Torre Alice Mannocci Vittoria Colamesta Valeria D’Egidio Cristina Sestili Antonietta Spadea

BACKGROUND The risk of getting influenza and pneumococcal disease is higher in cancer patients, and serum antibody levels tend to be lower in patients with hematological malignancy. OBJECTIVE To assess flu and pneumococcal vaccinations efficacy, effectiveness, and safety in onco-hematological patients. METHODS Two systematic reviews and possible meta-analysis were conducted to summarize the...

Journal: :Cureus 2023

Despite being a rare occurrence, multiple myeloma (MM) has been reported as an alternative cause of pleurisy, with approximately 50 documented cases in the literature so far. In this case report, we present clinical scenario patient who sought medical attention due to symptoms dyspnea, chest pain, and weight loss. Through comprehensive diagnostic evaluation, it was determined that patient's ple...

2013
Serge Cammilleri Marie Caroline Guzian Jean-Pierre Mattei Olivier Mundler Sandrine Guis

We showed the first image of (18)FDG-PET, which leads to a diagnosis of lymphoma in an atypical polyarthritis. About 4% of patients with lymphoma or leukemia suffered from rheumatologic paraneoplastic symptoms like arthralgia and about 10% of the patients with rheumatologic or neurologic clinical symptoms develop a solid cancer or hematological neoplasm. (18)FDG-PET is an interesting exam to id...

Journal: :Blood 1989
Y C Chen C H Wang I J Su C Y Hu M J Chou T H Lee D T Lin T Y Chung C H Liu C S Yang

Among 354 adult patients with either hematological malignancy or aplastic anemia, eight were positive for anti-HTLV-I antibodies; six of eight had received multiple transfusions. There was an approximately 3.5-fold increase (P less than .001) of HTLV-I seropositivity in the patients with hematologic disease (8 of 354, 2.23%) compared to the healthy adults older than 20 years (34 of 5252, .65%)....

Journal: :The Yale Journal of Biology and Medicine 1983
P. Lebowitz

All vertebrates possess a series of genes which are homologs of the oncogenic genes of acute transforming retroviruses. Two lines of evidence suggest that these genes may play a role in the development of human malignancy: (1) DNA from a variety of human tumors transforms NIH 3T3 mouse fibroblasts and the transforming genes from a number of carcinomas, sarcomas, and hematological malignancies h...

2017
Makoto Murata Yoshinobu Maeda Masayoshi Masuko Yasushi Onishi Tomoyuki Endo Seitaro Terakura Yuichi Ishikawa Chisako Iriyama Yoko Ushijima Tatsunori Goto Nobuharu Fujii Mitsune Tanimoto Hironori Kobayashi Yasuhiko Shibasaki Noriko Fukuhara Yoshihiro Inamoto Ritsuro Suzuki Yoshihisa Kodera Tadashi Matsushita Hitoshi Kiyoi Tomoki Naoe Tetsuya Nishida

The outcomes of cord blood transplantation with non-irradiated reduced-intensity conditioning for hematological malignancies need to be improved because of graft failure and delayed engraftment. Intrabone infusion of cord blood cells has the potential to resolve the problems. In this phase II study, 21 adult patients with hematological malignancy received intrabone transplantation of serologica...

2016
Mateja Kralj Juric Maxim Shevtsov Petra Mozes Justyna Ogonek Rachel E. Crossland Anne M. Dickinson Hildegard T. Greinix Ernst Holler Eva M. Weissinger Gabriele Multhoff

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main curative therapy for hematological malignancy such as leukemias, lymphomas, or multiple myelomas and some other hematological disorders. In this therapy, cure of hematological diseases relies on graft-versus-malignancy effects by allogenic immune cells. However, severe posttransplant treatment-associated complications su...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید